Through bulk-RNA sequencing, we identified immune-related pathways significantly upregulated in TNBC tumors acutely after systemic GEM administration, and we explored whether GEM-mediated constrain of TNBC tumor outgrowth is dependent on the presence of the highly inflammatory cytokine interferon-gamma (IFN-γ). The gene discussed is IFNG; the disease is neoplasm.